Management team
MARK C. POZNANSKY, MD, PHD, FRCP, FIDSA
DIRECTOR
Dr. Poznansky is an expert physician scientist and medical innovator who has combined these expertise together to found and direct the Vaccine and Immunotherapy Center (VIC) at Massachusetts General Hospital. VIC supports accelerated bench to bedside research and the development of novel vaccines and immunotherapies for…
MICHAEL V. CALLAHAN, MD, MSPH, DTM&H (U.K.)
DIRECTOR, CLINICAL TRANSLATION & MASS-CASUALTY THERAPEUTICS
Dr. Michael Callahan is a Staff Physician at MGH in internal medicine and infectious disease, and a clinical subject matter expert for international clinical trials for the Assistant Secretary of Public Health Preparedness (ASPR) of the Dept. of Health and Human Services, Washington, DC. Dr. Callahan has conducted federal-funded basic science and clinical…
ANN E. SLUDER, PHD
ASSOCIATE DIRECTOR
JEFFREY A. GELFAND, MD
SENIOR SCIENTIST
Dr. Gelfand is a Physician at MGH and Professor of Medicine, Part Time at Harvard Medical School. Dr. Gelfand has conducted laboratory and clinical research in immunology, inflammation and infection for over 40 years. Dr. Gelfand has focused on vaccines for infectious diseases and cancer. He initiated the programs on the…